JPMorgan Bullish on Palmer Square Capital BDC
JPMorgan gives an optimistic outlook for Palmer Square Capital BDC, assigning it an Overweight rating and $17.00 price target. The ...
- Latest
- Trending
JPMorgan gives an optimistic outlook for Palmer Square Capital BDC, assigning it an Overweight rating and $17.00 price target. The ...
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
Canadian asset management firm AGF Management has made a strategic investment in New York-based investment manager New Holland Capital as ...
Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...
Dogecoin is losing ground as investors shift focus to FLOKI and NuggetRush, newer meme coins with greater potential for growth ...
European blue-chip stocks known as the GRANOLAS group have outperformed the Magnificent 7 in the European market, accounting for 60% ...
Susquehanna adjusts price target for Expedia due to challenges in bookings and vacation rentals. Despite lower-than-expected bookings and subdued guidance ...
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
Crypto Finance has received licenses from BaFin in Germany, allowing them to extend their regulated services to institutional clients. The ...
Canadian cannabis producer Organigram Holdings Inc. has made its first shipment of bulk dried flower to Sanity Group, entering the ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.